TrialJournal of neuro-oncology2022

Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.

Marcello Marchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.